We are experiencing some temporary issues. The market data on this page are currently delayed. Please bear with us as we address this and restore your personalized lists.

U.S. Markets closed

Aralez Pharmaceuticals Inc. (ARLZ)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.2781-0.0119 (-4.10%)
At close: 3:59PM EDT
Full screen
Previous Close0.2900
Open0.2980
Bid0.2750 x 1000
Ask0.3000 x 800
Day's Range0.2751 - 0.3000
52 Week Range0.2751 - 2.9800
Volume658,486
Avg. Volume1,463,840
Market Cap19.41M
Beta1.07
PE Ratio (TTM)N/A
EPS (TTM)-1.7610
Earnings DateAug 7, 2018 - Aug 13, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2013-12-31
1y Target Est3.00
Trade prices are not sourced from all markets
  • Aralez Enters Into Amendment To Second Amended And Restated Facility Agreement
    PR Newswire17 days ago

    Aralez Enters Into Amendment To Second Amended And Restated Facility Agreement

    MISSISSAUGA, Ontario, June 29, 2018 /PRNewswire/ -- Aralez Pharmaceuticals Inc. (ARLZ) (ARZ.TO) ("Aralez" or the "Company") today announced that, in connection with its review of strategic alternatives, it entered into an Amendment (the "Amendment") to that certain Second Amended and Restated Facility Agreement, dated as of December 7, 2015, as amended on October 3, 2016 (the "Facility Agreement"), by and between the Company and Deerfield Partners, L.P. ("Deerfield") and certain affiliates of each party. Pursuant to the terms of the Amendment, interest due and payable on July 1, 2018 with respect to the loans under the Facility Agreement will be paid in kind, added to the outstanding principal amount of such loans and bear interest at the applicable interest rate of such loans.  The amount of interest paid in kind and the interest thereon is due and payable without premium or penalty on August 15, 2018 or such earlier date as loans maybe become due and payable.

  • Aralez Announces Voting Results From 2018 Annual Meeting Of Shareholders
    PR Newswire17 days ago

    Aralez Announces Voting Results From 2018 Annual Meeting Of Shareholders

    MISSISSAUGA, Ontario , June 29, 2018 /PRNewswire/ --  Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) ("Aralez" or the "Company") today announced the results of the matters voted ...

  • ACCESSWIRE18 days ago

    Anthera Pharma and Three Additional Stocks Under Scanner in the Biotech Space

    LONDON, UK / ACCESSWIRE / June 29, 2018 / If you want a free Stock Review on ANTH sign up now at www.wallstequities.com/registration. The nature of the operations of firms in the Biotech industry makes equities in this space more suited to aggressive, risk-tolerant investors.

  • Interested In Aralez Pharmaceuticals Inc (TSE:ARZ)? Here’s How It Performed Recently
    Simply Wall St.last month

    Interested In Aralez Pharmaceuticals Inc (TSE:ARZ)? Here’s How It Performed Recently

    Investors with a long-term horizong may find it valuable to assess Aralez Pharmaceuticals Inc’s (TSX:ARZ) earnings trend over time and against its industry benchmark as opposed to simply looking atRead More...

  • ACCESSWIRE2 months ago

    Free Daily Technical Summary Reports on Amicus Therapeutics and Three Other Biotech Stocks

    Stock Research Monitor: AMPE, ANTH, and ARLZ LONDON, UK / ACCESSWIRE / May 23, 2018 / If you want a free Stock Review on FOLD sign up now at www.wallstequities.com/registration . In today's pre-market ...

  • Is There An Opportunity With Aralez Pharmaceuticals Inc’s (TSE:ARZ) 39% Undervaluation?
    Simply Wall St.2 months ago

    Is There An Opportunity With Aralez Pharmaceuticals Inc’s (TSE:ARZ) 39% Undervaluation?

    Today I will be providing a simple run-through of the discounted cash flows (DCF) method to estimate the attractiveness of Aralez Pharmaceuticals Inc (TSX:ARZ) as an investment opportunity. If youRead More...

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of ARLZ earnings conference call or presentation 8-May-18 12:00pm GMT

    Q1 2018 Aralez Pharmaceuticals Inc Earnings Call

  • ACCESSWIRE2 months ago

    Today’s Research Reports on Stocks to Watch: Amedica Corporation and Aralez Pharmaceuticals

    NEW YORK, NY / ACCESSWIRE / May 9, 2018 / Aralez Pharmaceutical shares sunk on Tuesday after reporting first quarter results, despite a third consecutive quarter of positive adjusted EBITDA. Shares of Amedica had a better day yesterday exploding to a close of over 180% after providing Wall Street with some updates on its clinical study activities. The innovative biomaterial company saw its shares explode after providing an update on its clinical study activities including a Single Center Retrospective Comparative Study and a Multi-Center Retrospective Study.

  • Benzinga2 months ago

    Benzinga's Daily Biotech Pulse: Transenterix Rises, Mylan Earnings, Deutsche Bank Conference Underway

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on May 8) CONMED Corporation (NASDAQ: CNMD ) Enanta Pharmaceuticals Inc ...

  • Associated Press2 months ago

    Aralez Pharmaceuticals: 1Q Earnings Snapshot

    The Milton, Ontario-based company said it had a loss of 29 cents per share. The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was ...